OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	201
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	150
The deltoid muscle and the pattern of paresis in ALS	119
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	107
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	106
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	102
Richard Caton (1842-1926)	93
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	88
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	85
Complications of reversible cerebral vasoconstriction syndrome in relation to age	84
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	81
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	81
Tacrolimus-induced Parkinsonism	77
Explaining recovery from coma with multimodal neuroimaging	77
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	74
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	73
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	65
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	65
Neurological manifestation of HEV infection: still a rare disease entity?	62
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	61
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	59
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	58
Longitudinal predictors of health-related quality of life in isolated dystonia	58
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	56
The DeMyers: Marian (1922–2012) and William (1924–2008)	55

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	53
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	52
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	50
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	49
Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	48
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	46
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	46
Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	46
Correction to: Late‑onset Huntington’s disease associated with CAG repeat lengths of 30 and 31	46
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	45
International survey on the implementation of the European and American guidelines on disorders of consciousness	45
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	44
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	43
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	43
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	43
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	43
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	43
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	43